Technology
New evidence shows tirzepatide and semaglutide strongly protect the heart
2025-11-21 23:10
698 views
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabe...
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabetes. While companies have claimed large differences favoring their own medications, researchers found only modest distinctions between the two blockbuster GLP-1 drugs.
Related Articles
5 Reasons Why You Should Not Switch To An AI Browser
311 views
5 Phones With More Battery Life Than The iPhone 17 Pro Max
472 views
On Ukraine, Starmer sees what Trump refuses to: appeasement never works
869 views
Ukraine’s allies rally around Zelensky ahead of crunch talks as Trump offers lifeline to Kyiv
741 views